Evidence map›Paper›PMID 39437881›Full record

ReviewInfection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases2024

Dynamics of SARS-CoV-2 variants in West Africa: Insights into genomic surveillance in resource-constrained settings.

Josue Togo, Anou Moise Somboro, Oumar Dolo, Fatoumata Tata Traore, Ibrehima Guindo, Djeneba B Fofana, Eve Todesco, Anne-Geneviève Marcelin, Vincent Calvez, Jane Holl and 4 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Josue TogoUniversity Clinical Research Center, University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali; Département de Biologie médicale, Centre Hospitalier Universitaire Gabriel Toure, Bamako, Mali. Electronic address: josuetogo@icermali.org.
Anou Moise SomboroUniversity Clinical Research Center, University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali; Antimicrobial Research Unit, College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa.
Oumar DoloUniversity Clinical Research Center, University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali.
Fatoumata Tata TraoreUniversity Clinical Research Center, University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali.
Ibrehima GuindoNational Institute of Public Health (INSP), Bamako, Mali.
Djeneba B FofanaUniversity Clinical Research Center, University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali.
Eve TodescoSorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique (iPLESP), AP-HP, Hôpital Pitié-Salpêtrière, Laboratoire de virologie, F-75013 Paris, France.
Anne-Geneviève MarcelinSorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique (iPLESP), AP-HP, Hôpital Pitié-Salpêtrière, Laboratoire de virologie, F-75013 Paris, France.
Vincent CalvezSorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique (iPLESP), AP-HP, Hôpital Pitié-Salpêtrière, Laboratoire de virologie, F-75013 Paris, France.
Jane HollDivision of Biological Sciences, University of Chicago, Chicago, IL, USA.
Robert Leo MurphyInstitute for Global Health, Northwestern University, Chicago, USA.
Christophe RodriguezAP-HP, Henri Mondor Hospital, Department of Microbiology, University of Paris-Est, Créteil, France.
Mamoudou MaigaUniversity Clinical Research Center, University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali; Institute for Global Health, Northwestern University, Chicago, USA.
Almoustapha Issiaka MaigaUniversity Clinical Research Center, University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali; Département de Biologie médicale, Centre Hospitalier Universitaire Gabriel Toure, Bamako, Mali.

Funding

The Center for Innovation in Point-of-Care Technologies for HIV/AIDS atNorthwestern University (C-THAN) Supplemental RequestU54EB027049 · NIBIB · NORTHWESTERN UNIVERSITY · PI Chad J Achenbach · 2018 to 2026
$24.0M
HIV and Mycobacterial Disease in MaliD43TW010350 · FIC · UNIV OF SCIENCES, TECH & TECH OF BAMAKO · PI MAIGA, ALMOUSTAPHA ISSIAKA, MURPHY, ROBERT LEO · 2016 to 2025
$3.0M
FIC NIH HHS D43 TW010350NIBIB NIH HHS U54 EB027049
6 · The paper itself

Abstract

SARS-CoV-2 geno-surveillance has been challenging in West Africa. Despite the multiple challenges encountered, particularly in West Africa during the COVID-19 pandemic, efforts were made to circumscribe the spread of the disease and to provide methods and resources for surveillance. We aim to describe the dynamic of SARS-CoV-2 variants and highlight the efforts made in genomic surveillance in West Africa. Therefore, we proceeded to retrieve West African countries' SARS-CoV-2 data from public repository (GISAID) and then ensued to a descriptive statistical analysis. From the start of the pandemic till December 2023, we found less than a million COVID-19 cases notified within the West African region. Overall, the study population was 50.21 % Males with a median age of 37. Regarding genomic data, only 3.02 % of cases were sequenced and deposited in GISAID. Of the available sequence, we noted that most of the variants have circulated in West Africa before the official notification of the variants. Nigeria, Ghana, and Senegal provided together more than half of West Africa's originating sequences when Omicron and Delta variants were the most sequenced in West Africa.

Indexed as

COVID-19Genome, ViralSARS-CoV-2AdolescentAdultAfrica, WesternAgedChildChild, PreschoolFemaleGenomicsHumansMaleMiddle AgedPhylogenyYoung AdultEvolutionSARS-CoV-2Variants dynamicsWest-Africa

Identifiers

PMID39437881
PMCPMC11583778

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.